| 000 | 01878pam a22003011i 4500 | ||
|---|---|---|---|
| 001 | 013392013 | ||
| 003 | EG-GaU | ||
| 005 | 20210707144741.0 | ||
| 008 | 060117s2006 paua b 001 0 eng | ||
| 020 | _a078176064X (pbk.) | ||
| 040 |
_aStDuBDS _beng _erda _cStDuBDS _dUk _dEG-GaU |
||
| 082 | 0 | 4 |
_a615.784 _223 _bC.L.I. |
| 245 | 0 | 0 |
_aClinician's guide to antiepileptic drug use / _cMichael D. Privitera ... [and others]. |
| 264 | 1 |
_aPhiladelphia, Pa. ; _aLondon : _bLippincott Williams and Wilkins, _c2006. |
|
| 300 |
_aviii, 167 pages : _billustrations ; _c21 cm |
||
| 336 |
_atext _2rdacontent _btxt |
||
| 337 |
_aunmediated _2rdamedia _bn |
||
| 338 |
_avolume _2rdacarrier _bnc |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _aCarbamazepine -- Felbamate -- Gabapentin -- Lamotrigine -- Levetiracetam -- Oxcarbazepine -- Phenobarbital, primidone -- Phenytoin -- Pregabalin -- Tiagabine -- Topiramate -- Valproate acid -- Zonisamide. | |
| 520 | _aDesigned for quick point-of-care reference, this handbook offers evidence-based guidelines on use of antiepileptic drugs for seizures, psychiatric disorders, pain, and headache. Chapters cover all drugs, including the recently approved drug pregabalin. For each drug, the authors list FDA-approved indications and summarize the evidence for efficacy and tolerability from clinical trials for epileptic, psychiatric, pain, and headache indications. Also included are recommendations from professional societies such as the American Academy of Neurology, American Psychiatric Association, and Associat. | ||
| 650 | 7 |
_aAnticonvulsants _vHandbooks, manuals, etc. _9854 _2GU-sh |
|
| 650 | 7 |
_aEpilepsy _xChemotherapy _vHandbooks, manuals, etc. _9855 _2GU-sh |
|
| 650 | 7 |
_aAntidepressants. _9856 _2GU-sh |
|
| 700 | 1 |
_aPrivitera, Michael D., _9857 _eauthor. |
|
| 942 |
_cBK _2ddc |
||
| 999 |
_c320 _d320 |
||